Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
A propos de cet article
Formule linéaire :
CH3(CH2)10COOH
Numéro CAS:
Poids moléculaire :
200.32
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
205-582-1
Beilstein/REAXYS Number:
1099477
MDL number:
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderQuality Level
vapor pressure
1 mmHg ( 121 °C), 50 mmHg ( 210 °C)
assay
98%
bp
225 °C/100 mmHg (lit.)
mp
44-46 °C (lit.)
density
0.883 g/mL at 25 °C (lit.)
SMILES string
CCCCCCCCCCCC(O)=O
InChI
1S/C12H24O2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h2-11H2,1H3,(H,13,14)
InChI key
POULHZVOKOAJMA-UHFFFAOYSA-N
General description
Dodecanoic acid is a saturated fatty acid used as a starting material or intermediate in the synthesis of pharmaceuticals.
Application
Dodecanoic acid has been used as a reagent to synthesize MnFe2O4 magnetic nanoparticles by seed mediated growth method. It can undergo esterification with 2-ethylhexanol in the presence of sulfated zirconia catalyst to form 2-ethylhexanoldodecanoate, a biodiesel.
signalword
Danger
hcodes
Hazard Classifications
Eye Dam. 1
Classe de stockage
11 - Combustible Solids
wgk
WGK 1
flash_point_f
348.8 °F - closed cup
flash_point_c
176 °C - closed cup
ppe
Eyeshields, Gloves, type N95 (US)
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Solid Acid Catalysts for Biodiesel Production-Towards Sustainable Energy.
Kiss AA, et al.
advanced synthesis and catalysis, 348(1-2), 75-81 (2006)
Preparation of pyrenyl-based multifunctional nanocomposites for biomedical applications.
Lim EK and Chung BH
Nature Protocols, 11(2), 236-251 (2016)
Isaac Levy et al.
The Journal of clinical endocrinology and metabolism, 100(11), 4106-4113 (2015-09-01)
Adults with hypoparathyroidism have significant rates of nephrocalcinosis and impaired renal function. Little is known about the impact of hypoparathyroidism treatment on renal function in children. To determine the prevalence and predictors for renal abnormalities (nephrocalcinosis and decreased estimated glomerular
